SLS BIO CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,700 KRW | -0.11% |
|
-4.08% | -8.91% |
| 1 day | -0.11% | ||
| 1 week | -4.08% | ||
| Current month | -7.84% | ||
| 1 month | -8.56% | ||
| 3 months | -11.49% | ||
| 6 months | -1.26% | ||
| Current year | -8.91% |
1 week
4 660.00
5 000.00
1 month
4 660.005 190.00
Current year
4 660.006 500.00
1 year
3 955.0011 320.00
3 years
3 955.0012 050.00
5 years
3 955.0017 500.00
10 years
3 955.0017 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Young-Tae Lee
CEO | Chief Executive Officer | 69 | 06-12-31 |
Bong-Hui Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Jong-Soo Kim
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Young-Tae Lee
CEO | Chief Executive Officer | 69 | 06-12-31 |
Jong-Soo Kim
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-12-31 |
Hyeon-Chan Jo
BRD | Director/Board Member | 72 | 17-07-27 |
SLS BIO Co., Ltd, formerly SLS Co., Ltd, is a Korea-based company primarily engaged in provision of drug development supporting services and pharmaceutical product QC services. The Company's services include bioequivalence study, drug analysis, metabolites analysis, heavy metal analysis, toxic substance analysis, toxicant test, QC test for imported products, dissolution test and TK study.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.91% | 23.32M | |
| -17.89% | 8.25B | |
| +39.20% | 3.57B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
- Stock Market
- Equities
- A246250 Stock
